Synthesis of antineoplaston A10 analogs as potential antitumor agents. 1998

B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
College of Pharmacy, Chonnam National University, Kwangju, Korea.

Several aniline mustard analogues were obtained by introducing N,N-bis(2-chloroethyl)amino moiety to phenyl ring of A10 analogues in order to increase reactivity of A10 analogs and selectivity into DNA. The in vitro antitumor activity of synthesized compounds was evaluated using five different solid tumor cell lines by SRB method. Aniline mustard analogues exhibited more potent antitumor activity than A10 analogs. Especially, m-aniline mustard of benzoyl analogue displayed remarkable antitumor activity.

UI MeSH Term Description Entries
D010881 Piperidones A family of saturated heterocyclic organic compounds which contain one nitrogen atom and a carbonyl group in the ring structure. Piperidone
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006865 Hydrogenation Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed) Hydrogenations
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D044482 Benzeneacetamides Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES. 2-Phenylacetamides

Related Publications

B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
May 1975, Journal of pharmaceutical sciences,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
December 1994, Archives of pharmacal research,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
December 1979, Journal of pharmaceutical sciences,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
July 1981, Journal of pharmaceutical sciences,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
December 2009, Molecules (Basel, Switzerland),
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
June 2011, Archiv der Pharmazie,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
June 1982, Journal of pharmaceutical sciences,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
April 1985, European journal of cancer & clinical oncology,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
April 2006, Bioorganic & medicinal chemistry,
B G Choi, and O Y Kim, and B H Chung, and W J Cho, and S H Cheon, and S U Choi, and C O Lee
November 1971, Journal of medicinal chemistry,
Copied contents to your clipboard!